Inlexzo

Active Ingredient(s): Gemcitabine Hydrochloride
FDA Approved: * September 9, 2025
Pharm Company: * JANSSEN BIOTECH
Category: Cancer

Gemcitabine, with brand names including Gemzar,[1] is a chemotherapy medication.[2] It treats cancers including testicular cancer,[3] breast cancer, ovarian cancer, non-small cell lung cancer, pancreatic cancer, and bladder cancer.[2][4] It is administered by intravenous infusion.[2] It acts against neoplastic growth, and it inhibits the replication of Orthohepevirus A, the causative agent of Hepat... [wikipedia]

* May have multiple approval dates, manufacturers, or labelers.

Dosage List

Inlexzo 225 mg Intravesical System
NDC: 57894-225
Labeler:
Janssen Biotech, Inc

Related Brands

Drugs with the same active ingredients